- Top Workplaces
- Seaport Therapeutics
Seaport Therapeutics
Seaport Therapeutics (Nasdaq: SPTX) is a clinical-stage therapeutics company headquartered in Seaport Boston. Founded with a mission to transform the treatment of depression, anxiety, and other neuropsychiatric disorders, Seaport is advancing innovative medicines designed to improve the lives of patients and their families. The company brings together experienced drug developers, scientists, and innovators who share a commitment to advancing better treatment options for the more than one billion people worldwide living with mental illness. Guided by its purpose to unlock better days for those impacted by these debilitating conditions, Seaport fosters a collaborative, entrepreneurial culture grounded in service, excellence, and teamwork to make a meaningful impact on patients’ lives.
Purpose
To unlock better days for people living with depression, anxiety, and other debilitating neuropsychiatric conditions.
Vision
To turn the tide on mental health by developing better treatment options for the more than one billion people living with mental illness worldwide.
Mission
We were founded with a mission to transform the treatment of neuropsychiatric disorders and improve patients’ lives.
Additional Culture Details
Seaport Therapeutics has a collaborative, innovative culture that embodies our values of service to patients -- making an impact for those living with anxiety, depression, and other debilitating neuropsychiatric conditions -- with a “we own it” mentality, demonstrating entrepreneurial spirit and technical excellence while fostering teamwork and continuous improvement.
Values
- Service
- We exist to serve those impacted by mental health conditions.
Headquarters
Boston, MA
Employees
59 US Employees
Industry
Biotechnology
Company Snapshots
